These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 7970549

  • 1. Visual prognosis in patients with Behçet's disease receiving colchicine, systemic corticosteroid or cyclosporin.
    Hayasaka S, Kawamoto K, Noda S, Kodama T.
    Ophthalmologica; 1994; 208(4):210-3. PubMed ID: 7970549
    [Abstract] [Full Text] [Related]

  • 2. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
    Takeuchi M, Asukata Y, Kawagoe T, Ito N, Nishide T, Mizuki N.
    Ocul Immunol Inflamm; 2012 Jun; 20(3):193-7. PubMed ID: 22486264
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of corticosteroids and cyclosporin in the treatment of retinal vasculitis in patients with Behçet's disease.
    Ermakova NA.
    Adv Exp Med Biol; 2003 Jun; 528():563-5. PubMed ID: 12918765
    [No Abstract] [Full Text] [Related]

  • 4. Could nicotine be beneficial for Behçet's disease?
    Kaklamani VG, Markomichelakis N, Kaklamanis PG.
    Clin Rheumatol; 2002 Aug; 21(4):341-2. PubMed ID: 12296287
    [No Abstract] [Full Text] [Related]

  • 5. A case of Behçet's disease treated with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
    Hirano T, Ohguro N, Hohki S, Hagihara K, Shima Y, Narazaki M, Ogata A, Yoshizaki K, Kumanogoh A, Kishimoto T, Tanaka T.
    Mod Rheumatol; 2012 Apr; 22(2):298-302. PubMed ID: 21748365
    [Abstract] [Full Text] [Related]

  • 6. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.
    Kazokoglu H, Saatçi O, Cuhadaroglu H, Eldem B.
    Ann Ophthalmol; 1991 Apr; 23(4):148-51. PubMed ID: 2064258
    [Abstract] [Full Text] [Related]

  • 7. Low dose cyclosporin-A therapy in Behçet's disease.
    Sajjadi H, Soheilian M, Ahmadieh H, Hassanein K, Parvin M, Azarmina M, Ehyaee V, Amiransari B.
    J Ocul Pharmacol; 1994 Apr; 10(3):553-60. PubMed ID: 7836864
    [Abstract] [Full Text] [Related]

  • 8. Cyclosporin-A therapy in severe uveitis of Behçet's disease.
    Süllü Y, Oge I, Erkan D, Aritürk N, Mohajeri F.
    Acta Ophthalmol Scand; 1998 Feb; 76(1):96-9. PubMed ID: 9541443
    [Abstract] [Full Text] [Related]

  • 9. Epidemiological features and visual prognosis of Behçet's disease.
    Ando K, Fujino Y, Hijikata K, Izawa Y, Masuda K.
    Jpn J Ophthalmol; 1999 Feb; 43(4):312-7. PubMed ID: 10482479
    [Abstract] [Full Text] [Related]

  • 10. A case of tuberculous meningoencephalitis in a patient with Behçet's disease.
    Iliopoulos A, Kedikoglou S, Laxanis S, Kourouklis S, Katsaros E.
    Clin Rheumatol; 2006 Feb; 25(1):121-2. PubMed ID: 15902513
    [No Abstract] [Full Text] [Related]

  • 11. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.
    Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G.
    Lancet; 1989 May 20; 1(8647):1093-6. PubMed ID: 2566048
    [Abstract] [Full Text] [Related]

  • 12. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet's disease: a randomised trial.
    Demiroglu H, Ozcebe OI, Barista I, Dündar S, Eldem B.
    Lancet; 2000 Feb 19; 355(9204):605-9. PubMed ID: 10696980
    [Abstract] [Full Text] [Related]

  • 13. Use of colchicine in Behçet's syndrome.
    Sander HM, Randle HW.
    Cutis; 1986 May 19; 37(5):344-8. PubMed ID: 3519102
    [Abstract] [Full Text] [Related]

  • 14. Colchicine in Behçet's disease with major vessel thrombosis.
    Celik G, Kalaycioğlu O, Durmaz G.
    Rheumatol Int; 1996 May 19; 16(1):43-4. PubMed ID: 8783422
    [No Abstract] [Full Text] [Related]

  • 15. Combined cyclosporine and corticosteroid therapy for sight-threatening uveitis in Behçet's disease.
    Whitcup SM, Salvo EC, Nussenblatt RB.
    Am J Ophthalmol; 1994 Jul 15; 118(1):39-45. PubMed ID: 8023874
    [Abstract] [Full Text] [Related]

  • 16. [A case of Behçet's disease associated with neuromyopathy induced by combination therapy with colchicine and cyclosporin].
    Fujii Y, Arimura Y, Takahashi N, Toki T, Marumo T, Yoshihara K, Nakabayashi K, Yamada A.
    Ryumachi; 2003 Feb 15; 43(1):44-50. PubMed ID: 12692989
    [Abstract] [Full Text] [Related]

  • 17. Optic nerve involvement in neuro-Behcet's disease.
    Nakamura T, Takahashi K, Kishi S.
    Jpn J Ophthalmol; 2002 Feb 15; 46(1):100-2. PubMed ID: 11853723
    [Abstract] [Full Text] [Related]

  • 18. Cyclosporine in Behçet's disease resistant to conventional therapy.
    Caspers-Velu LE, Decaux G, Libert J.
    Ann Ophthalmol; 1989 Mar 15; 21(3):111-6, 118. PubMed ID: 2735696
    [Abstract] [Full Text] [Related]

  • 19. Late-onset Behçet's disease does not correlate with indolent clinical course: report of seven Taiwanese patients.
    Tsai J, Chen GS, Lu YW, Wu CS, Lan CC.
    J Eur Acad Dermatol Venereol; 2008 May 15; 22(5):596-600. PubMed ID: 18266686
    [Abstract] [Full Text] [Related]

  • 20. Prognosis in Behcet's disease.
    Pivetti Pezzi P, Gasparri V, De Liso P, Catarinelli G.
    Ann Ophthalmol; 1985 Jan 15; 17(1):20-5. PubMed ID: 3977213
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.